The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequencing of systemic therapies in advanced NSCLC with MET exon 14 skipping mutation: A multicenter experience.
 
Sally C. M. Lau
No Relationships to Disclose
 
Kirstin Perdrizet
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Roche
 
Danilo Giffoni de Mello Morais Mata
No Relationships to Disclose
 
Andrea S. Fung
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; roche (Inst); Takeda
 
Penelope Ann Bradbury
Honoraria - Abbvie; Lilly; Merck
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim
(OPTIONAL) Uncompensated Relationships - Abbvie; AstraZeneca
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Daiichi Sankyo; Merck Serono; Takeda
Consulting or Advisory Role - AstraZeneca; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Adrian G. Sacher
Honoraria - Amgen; AstraZeneca; Bayer; BMS; Genentech/Roche; KisoJi Biotechnology; Merck; Pfizer; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; BMS; Genentech/Roche; KisoJi Biotechnology; Merck; Pfizer
Research Funding - AstraZeneca; Genentech/Roche
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Gritstone Bio; Pfizer
 
Brandon Sheffield
Stock and Other Ownership Interests - AstraZeneca; GHD GesundHeits; Pfizer; Roche
Honoraria - Amgen; AstraZeneca; Bayer; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Lilly; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Biocartis; Pfizer; Roche; Thermo Fisher Scientific
 
David Hwang
Honoraria - Bayer; Novartis
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); EMD Serono (Inst); Merck (Inst); Novartis (Inst); Takeda (Inst)
 
Ming Sound Tsao
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst)
 
Susanna Y. Cheng
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck
 
Parneet Cheema
Honoraria - AstraZeneca; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb; Emd serono; Genomic Health; Merck; Novartis; Pfizer; Roche; Takeda
 
Natasha B. Leighl
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Xcovery
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Roche